Vol. 17/No. 24 | OncologyLive

A Time for Hope

January 18, 2017

Although lung cancer still causes more deaths than any other type of malignancy not only in the United States but throughout the world, there’s a sense of excitement in the air these days when it comes to helping people with this disease.

Targeted Therapy Makes Inroads in Gastroesophageal Cancer

December 15, 2016

Gastroesophageal cancer (GEC) is a complex disease, encompassing cancers with different histological and molecular subtypes. Growing insight into the molecular biology of GEC is poised to change the treatment landscape for this disease, although many questions remain unanswered.

Tepotinib Takes Aim at Novel MET Mutation in Lung Cancer Trial

December 12, 2016

Tepotinib, an investigational small molecule that targets a recently identified aberration in the MET gene, is moving forward rapidly in clinical development for patients with non–small cell lung cancer who harbor the mutation, raising hopes that a more specific attack on the signaling pathway will lead to a new therapy for a significant subgroup of individuals with the disease.

Patient-Friendly Policies Extend to Decision Making

December 12, 2016

It was not that long ago that decisions regarding cancer management were essentially made exclusively by the treating physician, with patients simply being informed of “the plan” for their treatment.